BIM — Biomerieux SA Cashflow Statement
0.000.00%
Last trade - 00:00- €13.02bn
- €13.15bn
- €3.98bn
- 99
- 16
- 25
- 41
Annual cashflow statement for Biomerieux SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 403 | 598 | 441 | 323 | 425 |
| Depreciation | |||||
| Non-Cash Items | 159 | 177 | 265 | 244 | 111 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -190 | -9 | -297 | -291 | -194 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 583 | 825 | 475 | 445 | 667 |
| Capital Expenditures | -278 | -290 | -287 | -338 | -346 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 12.3 | -17.2 | -241 | -151 | -14 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -265 | -307 | -528 | -489 | -360 |
| Financing Cash Flow Items | -2.4 | — | -0.1 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -176 | -141 | -244 | -122 | -213 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 107 | 416 | -259 | -195 | 109 |